Comparative effectiveness and safety between apixaban, dabigatran, edoxaban, and rivaroxaban among patients with atrial fibrillation: a multinational population …

WCY Lau, CO Torre, KKC Man, HM Stewart… - Annals of Internal …, 2022 - acpjournals.org
Background: Current guidelines recommend using direct oral anticoagulants (DOACs) over
warfarin in patients with atrial fibrillation (AF), but head-to-head trial data do not exist to …
被引用次数：43 相关文章

Comparative Effectiveness and Safety between Apixaban, Dabigatran, Edoxaban, and Rivaroxaban among Patients with Atrial Fibrillation: A Multinational Population …

WCY Lau, CO Torre, KKC Man… - Annals of Internal …, 2022 - discovery.ucl.ac.uk
Background: Current guidelines recommend using direct oral anticoagulants (DOACs) over
warfarin in patients with atrial fibrillation (AF), but head-to-head trial data do not exist to …

Comparative Effectiveness and Safety Between Apixaban, Dabigatran, Edoxaban, and Rivaroxaban Among Patients With Atrial Fibrillation: A Multinational Population …

WCY Lau, CO Torre, KKC Man, HM Stewart… - Annals of Internal …, 2022 - europepmc.org
Background Current guidelines recommend using direct oral anticoagulants (DOACs) over
warfarin in patients with atrial fibrillation (AF), but head-to-head trial data do not exist to …

[引用][C] Comparative Effectiveness and Safety Between Apixaban, Dabigatran, Edoxaban, and Rivaroxaban Among Patients With Atrial Fibrillation

CY Lau, CO Torre, KCK Man, HM Stewart… - Annals of Internal …, 2022 - hub.hku.hk
HKU Scholars Hub: Comparative Effectiveness and Safety Between Apixaban, Dabigatran,
Edoxaban, and Rivaroxaban Among Patients With Atrial Fibrillation Skip navigation HKU …

Comparative Effectiveness and Safety Between Apixaban, Dabigatran, Edoxaban, and Rivaroxaban Among Patients With Atrial Fibrillation: A Multinational Population …

WCY Lau, CO Torre, KKC Man… - Annals of internal …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Current guidelines recommend using direct oral anticoagulants (DOACs) over
warfarin in patients with atrial fibrillation (AF), but head-to-head trial data do not exist to …

Comparative Effectiveness and Safety Between Apixaban, Dabigatran, Edoxaban, and Rivaroxaban Among Patients With Atrial Fibrillation: A Multinational Population …

WCY Lau, CO Torre, KKC Man, HM Stewart… - Annals of Internal …, 2022 - vbn.aau.dk
BACKGROUND: Current guidelines recommend using direct oral anticoagulants (DOACs)
over warfarin in patients with atrial fibrillation (AF), but head-to-head trial data do not exist to …